Skip to main content
. Author manuscript; available in PMC: 2014 Mar 1.
Published in final edited form as: J Magn Reson Imaging. 2012 Sep 21;37(3):746–751. doi: 10.1002/jmri.23810

Table 1.

Comparison of mean values (±standard deviation) of pharmacokinetic parameters of muscle and tumor regions for the 19 dynamic contrast-enhanced (DCE)-MRI experiments in our study with those from DCE-MRI studies in small rodentsa

Parameter Ktrans/min−1 kep/min−1 ve vp
Muscle (our study) 0.038 ± 0.025 0.66 ± 0.48 0.060 ± 0.014 0.033 ± 0.021
Muscle (literature) 0.044 ± 0.033b 0.55c 0.080 ± 0.040d 0.028 ± 0.008e

Tumor (our study) 0.082 ± 0.071 0.82 ± 0.80 0.121 ± 0.075 0.093 ± 0.051
Tumor f (literature) 0.062 ± 0.017 0.41c 0.15 ± 0.04 0.04 ± 0.01
a

References given in parentheses.

b

Ktrans is the average value for perivertebral muscle in mice obtained from 2 separate contrast agent injections (16).

c

kep was calculated by Eq. 3, using values reported for Ktrans and ve in literature (16, 17).

d

ve values are for rat skeletal muscle (16).

e

vp is the average value obtained from 2 different limb muscles in rabbit (15).

f

Values for orthotopic BN472 breast tumor xenografts in Brown Norway rat (16).